Shiseido faces tough turnaround after cosmetics missteps

Japanese cosmetics giant Shiseido is grappling with its biggest challenge in decades, stemming from a costly misfire in North America and eroding market share to nimble Asian rivals. Six years ago, the company spent $845 million acquiring the American brand Drunk Elephant to tap into younger customers, but has since written off more than half the investment due to falling profits and sales.

Shiseido, once a formidable challenger to L’Oreal and Estee Lauder Companies, is now navigating its most significant hurdles in decades. The Japanese cosmetics maker has been hit by a costly blunder in North America and the loss of ground to agile Asian competitors.

Six years ago, Shiseido invested $845 million to acquire the American brand Drunk Elephant, aiming to attract a younger demographic. However, declining profits and sales have forced the company to impair more than half of that investment. This setback underscores broader challenges in the North American market.

Shiseido’s difficulties highlight the rapid shifts in the global cosmetics industry, driven by evolving social trends, accelerated product cycles, and competition from South Korean and Chinese rivals. Companies like Amorepacific and Kolmar Korea have surpassed Shiseido, becoming the largest exporters of cosmetics to the U.S. These agile players have outmaneuvered the Japanese firm, illustrating how quickly beauty brands can falter in a dynamic market.

Related Articles

Executives from Puig and Estée Lauder shaking hands amid $40B merger talks, with stock charts showing price swings and luxury beauty products on display.
Image generated by AI

Puig and Estée Lauder in talks for potential $40 billion merger

Reported by AI Image generated by AI

Puig and The Estée Lauder Companies disclosed after Monday's market close that they are discussing a possible business combination, with no agreement reached. Puig notified Spain's CNMV on March 23, 2026. The deal could create a $40 billion beauty group with $20 billion in combined sales, prompting Estée Lauder shares to drop 7.7% while Puig's rose 11%.

Japanese retailer Muji is betting on its value-for-money skincare products to drive growth at home and abroad. These items, featuring simple formulations and transparent labeling, have doubled in revenue recently. The company targets a significant operating profit increase by 2028.

Reported by AI

Unilever CEO Fernando Fernández has led a comprehensive corporate overhaul for a year. The food division was recently spun off for $66 billion into a joint venture with a US spice company. The focus shifts to beauty, wellness, and personal care.

Japan’s Nikkei share average fell 0.6% on February 17, 2026, to 56,451.43, dragged by SoftBank Group’s decline as post-election enthusiasm waned and U.S. markets were closed for Presidents’ Day, leaving investors short on trading cues. The index marked a fourth consecutive session of losses. Analysts pointed to a lack of catalysts and technical factors as the main drivers.

Reported by AI

Sun Pharmaceutical Industries' shares surged more than 9% following the announcement of its $11.75 billion acquisition of US-based Organon & Co. The deal targets bolstering the Indian company's innovative medicines and positioning it strongly in biosimilars and women's health markets. Organon is recognized as a global leader in women's health.

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline